Document is current

Article History

Received: 11 January 2023

Revised: 25 July 2023

Accepted: 9 August 2023

First Online: 2 September 2023

Competing interests

: All authors declare no real or perceived conflicts of interest that could affect the study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit for publication. For full disclosure, we provide here an additional list of other author’s commitments and funding sources that are not directly related to this study: M.W.H. receives research funding unrelated to this project from the NIH, Wisconsin Partnership Program, and Meriter Foundation. D.J.A. is a consultant for Baxter, Nuwellis, Medtronic Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from NIH, Baxter, Nuwellis, Medtronic, Bioporto, and Seastar. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow. J.R.C. is a consultant for Medtronics and investor in Zorro-Flow. She receives funding for research not related to this project from the NIH. She is Vice-President of the Neonatal Kidney Collaborative. R.Guillet is a consultant for NEMA Research. She receives funding for research not related to this project from NIH. C.S. is a consultant for AM Pharma which is unrelated to the content in this manuscript. Meredith Schuh receives research funding unrelated to this project from NIH and Otsuka

: Consent was required for parent study but not for this secondary analysis.